Abstract
Assimilation of artificial intelligence (AI) and machine learning (ML) into clinical practice is a potential driver for reengineering precision nuclear medicine and molecular imaging capabilities. Across members of the nuclear medicine community there is a spectrum of opinions and positions in relation to the role and capability of AI now, and in the future. While the applications of AI, ML, and deep learning (DL) in nuclear medicine and molecular imaging are growing quickly; there remain a number of barriers. The opportunities and applications emerging in this space may transform the molecular imaging landscape. Despite concerns with respect to the impact of AI on the workforce, deep assimilation of an AI program in nuclear medicine and molecular imaging is likely to expand the workforce while improving clinical outcomes. This chapter expressly considers the assimilation of AI, ML, and DL into routine clinical practice in molecular imaging but excludes the wealth of applications that enrich research practice.
Original language | English |
---|---|
Title of host publication | Artificial intelligence/Machine learning in nuclear medicine and hybrid imaging |
Editors | Patrick Veit-Haibach, Ken Herrmann |
Place of Publication | Cham, Switzerland |
Publisher | Springer |
Chapter | 7 |
Pages | 87-108 |
Number of pages | 22 |
Edition | 1st |
ISBN (Electronic) | 9783031001192 |
ISBN (Print) | 9783031001185 |
DOIs | |
Publication status | Published - 2022 |